These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7011717)

  • 1. Biologic activities of biosynthetic human insulin in healthy volunteers and insulin-dependent diabetic patients monitored by the artificial endocrine pancreas.
    Raptis S; Karaiskos C; Enzmann F; Hatzidakis D; Zoupas C; Souvatzoglou A; Diamantopoulos E; Moulopoulos S
    Diabetes Care; 1981; 4(2):155-62. PubMed ID: 7011717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system.
    Klier M; Kerner W; Torres AA; Pfeiffer EF
    Diabetes Care; 1981; 4(2):193-5. PubMed ID: 7011725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE; Buysschaert M; Lambotte L
    Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of a somatostatin analog on insulin requirement and hormone levels in 6 insulin-dependent juvenile-onset diabetics subjected to artificial pancreas.
    Lenti G; Trovati M; Lorenzati R; Vitelli F; Tagliaferro V; Marocco A; Pagano G
    Acta Diabetol Lat; 1980; 17(1):9-14. PubMed ID: 6106342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The artificial endocrine pancreas in clinical medicine and in research].
    Pfeiffer EF; Beischer W; Thum C; Clemens AH
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():279-96. PubMed ID: 796524
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologic and immunologic in vivo and in vitro studies with biosynthetic human insulin.
    Federlin K; Laube H; Velcovsky HG
    Diabetes Care; 1981; 4(2):170-4. PubMed ID: 7011720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of biosynthetic human insulin and pork insulin during rest, food ingestion, and physical work in insulin-dependent diabetic subjects using a glucose controlled insulin infusion system.
    Beyer J; Weber T; Schulz G; Hassinger W; Westerburg A; Cordes U
    Diabetes Care; 1981; 4(2):189-92. PubMed ID: 7011724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semisynthetic human insulin and purified pork insulin do not differ in their biological potency.
    Arias P; Kerner W; Navascués I; Schäfauer G; Pfeiffer EF
    Klin Wochenschr; 1984 Dec; 62(24):1145-50. PubMed ID: 6397660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
    Neuhaus C; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of biosynthetic human insulin to erythrocytes of normal and insulin-dependent diabetic subjects: comparison with pork and human pancreatic insulin.
    Bachmann W; Sieger C; Lacher F; Lotz N
    Diabetes Care; 1981; 4(2):215-9. PubMed ID: 7011730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control.
    Fukuda M; Tanaka A; Tahara Y; Ikegami H; Yamamoto Y; Kumahara Y; Shima K
    Diabetes; 1988 Jan; 37(1):81-8. PubMed ID: 3275557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different potencies of biosynthetic human and purified porcine insulin.
    Schlüter KJ; Enzmann F; Kerp L
    Horm Metab Res; 1983 Jun; 15(6):271-4. PubMed ID: 6347857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 16. [Artificial pancreas: clinical and therapeutic value in 11 patients (author's transl)].
    Buysschaert M; Lambotte L; Lambert AE
    Nouv Presse Med; 1979 Jul 14-28; 8(32):2597-601. PubMed ID: 386266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on B-cell function after segmental pancreatic allotransplantation in diabetic patients.
    Gunnarsson R; Collste H; Lundgren G; Ostman J; Groth CG
    Horm Metab Res Suppl; 1983; (13):42-6. PubMed ID: 6345317
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of human proinsulin on blood glucose control and metabolic instability in type 1 diabetes mellitus.
    Bock E; Quabbe HJ
    Diabetes Res; 1989 Apr; 10(4):165-9. PubMed ID: 2692943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of glucose homeostasis in insulin-dependent diabetics using a miniature insulin infusion pump with a fixed profile.
    Køolendorf K; Bojsen J; Løorup B
    Diabetologia; 1980; 18(2):141-5. PubMed ID: 6988273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin binding, biologic activity, and metabolism of biosynthetic human insulin.
    Olefsky JM
    Diabetes Care; 1981; 4(2):244-7. PubMed ID: 7011736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.